Loading clinical trials...

Retapamulin as a Decolonizing Agent for MRSA | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT03304873

Retapamulin as a Decolonizing Agent for MRSA

The purpose of this study is to investigate the efficacy of retapamulin to reduce carriage of MRSA via a randomized, double-blind, placebo-controlled clinical study testing retapamulin among patients ...

Lead sponsor: NYU Langone Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

MRSA Decolonization in Complicated Carriage

NCT05268120 · MRSA

RECRUITINGNA

Safety and Efficacy of Fecal Microbiota Transplantation

NCT04014413 · Crohn Disease, Ulcerative Colitis, and more

Enrolling By InvitationPhase 4

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

NCT04297592 · Infections Joint Prosthetic, Overweight or Obesity, and more

COMPLETEDPhase 4

Staph Household Intervention for Eradication (SHINE)

NCT02572791 · Skin and Subcutaneous Tissue Bacterial Infections, Staphylococcus Aureus, and more

COMPLETEDPhase 3

Optimal Treatment of MRSA Throat Carriers

NCT04104178 · MRSA, MRSA Colonization

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 19, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment47

Start dateDec 2017

Last updatedMar 19, 2020

Condition

MRSA

Locations shown

New York University School of Medicine

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions